Physician profile
Mark Hasenauer
NPI 1710372271
$34,920.30
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 77% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.90 · 2020: $10K · 2021: $10K · 2022: $1,486 · 2023: $464 · 2024: $1,313 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,743 · Travel and Lodging: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,044.54 |
| Food and Beverage | $1,742.67 |
| Travel and Lodging | $1,461.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,136.67 | 2020-2021 | |
| Depuy Synthes Products, INC. | $6,212.42 | 2025 | Velys |
| Medical Device Business Services, INC. | $4,808.91 | 2023-2025 | Attune, Velys |
| Zimmer Biomet Holdings, INC. | $2,760.30 | 2022-2025 | Persona, Avitus Bone Harvester, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $656.96 | 2021-2025 | Attune, Na |
| Stryker Corporation | $301.39 | 2022-2024 | Mako |
| Convatec INC. | $21.90 | 2019 | |
| Ferring Pharmaceuticals INC. | $21.75 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hasenauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.